一种基于T细胞的SARS-CoV-2尖端蛋白疫苗在没有抗体的情况下提供保护
Juan Shi1, Jian Zheng2, Xiujuan Zhang3
1Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, USA.
JCI insight
|March 8, 2024
概括
这项研究开发了一种基于T细胞的针对SARS-CoV-2的疫苗,该疫苗可以保护小鼠免受严重疾病的侵害,并减少病毒载量. 这种方法提供了对未来变异的潜在保护,即使它们逃避了抗体反应.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 目前的SARS-CoV-2 (COVID-19) 疫苗主要依赖于尖端特异性抗体,这些抗体越来越多地被新兴变异所规避.
- 在SARS-CoV-2的进一步突变可能导致对现有的基于抗体的疫苗完全抵抗.
研究的目的:
- 调查单独T细胞介导免疫的潜力,以防止SARS-CoV-2的感染.
- 开发和评估一种基于T细胞的新型疫苗策略,针对SARS-CoV-2尖端蛋白的保护区域.
主要方法:
- 一种基于T细胞的疫苗是通过重新排列SARS-CoV-2尖端序列并将它们附加到ubiquitin.
- 接种了小鼠的免疫,并证实了疫苗在没有抗体的情况下诱导T细胞反应的能力.
- 接种疫苗的小鼠接受了SARS-CoV-2野生型或Omicron变种菌株的挑战,并通过监测存活率,体重减轻和病毒性肺部标位来评估保护.
- 通过细胞枯竭实验评估了CD4+和CD8+T细胞在保护中的作用.
主要成果:
- 免疫引发了强大的SARS-CoV-2特异性T细胞反应,但没有可检测的抗体.
- 用T细胞为基础的疫苗接种疫苗的小鼠显示出对野生型SARS-CoV-2挑战的死亡率和体重减轻的显著保护.
- 在疫苗接种小鼠的肺部观察到病毒标位的显著降低,这些小鼠接受了野生型或Omicron变种的挑战.
- CD4+或CD8+T细胞的耗尽取消了保护作用,突出了T细胞的关键作用.
结论:
- 独立于抗体的T细胞介导免疫力,可以对SARS-CoV-2感染和疾病提供显著的保护.
- 基于T细胞的疫苗策略证明了对野生型和Omicron变种菌株的有效性.
- 针对SARS-CoV-2尖端蛋白内保存的T细胞表位,为开发针对当前和未来变种有效的疫苗提供了一个有希望的方法.
更多相关视频
10:25Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
4.6K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
相关概念视频
Vaccinations
44.5K
Overview
44.5K
Conjugated Proteins
18.3K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.3K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Cross-reactivity
31.1K
Overview
31.1K
Immune Response Against Viral Pathogens
781
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
781
Active versus Passive Immunity
642
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
642
